» Articles » PMID: 30400916

Predictors of Cervical Cancer Screening Among Kenyan Women: Results of a Nested Case-control Study in a Nationally Representative Survey

Overview
Publisher Biomed Central
Specialty Public Health
Date 2018 Nov 8
PMID 30400916
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cervical cancer is a major public health concern in Kenya. It is the leading cause of cancer morbidity and mortality among women. Although screening is an effective prevention method, uptake is low among eligible women. Little is known about predictors of cervical cancer screening uptake. This study explored relationship between uptake of cervical cancer screening, socio-demographic, behavioral and biological risk factors.

Methods: Nested case-control study within STEPS survey, a population-based cross-sectional household survey conducted between April and June 2015.Cases were women who had undergone cervical cancer screening and controls were unscreened women. Study participants were women eligible for cervical cancer screening (30-49 years). Variables included socio-demographic; behavioral risk factors such as physical activity, tobacco and alcohol use diet and biological factors like diabetes and hypertension. Outcome of interest was cervical cancer screening. Data analysis was done using STATA version 14. Logistic regression model was used to assess relationship between cervical cancer screening and socio-demographic, behavioral and biological risk factors.

Results: Of 1180 women interviewed, 16.4% (n = 194) had been screened for cervical cancer. Of unscreened women (n = 986), 67.9% were aware of cervical cancer screening. Higher screening rates were observed in more educated women (25.2%), highest income quintile (29.6%) and living in urban areas (23%) than in women with no formal education (3.2%), poorest (3.6%) and living in rural areas (13.8%). Younger women (35-39) and those with low High-density lipoprotein (HDL) were less likely to be screened [OR = 0.56; 95% CI = (0.34, 0.93); p-value = 0.025] and [OR = 0.51; 95% CI = (0.29, 0.91); p = value 0.023] respectively. Self-employed women, those in the fourth wealth quintile, binge drinkers, high sugar consumption and insufficient physical activity were more likely to be screened [OR 2.55 (1.12, 5.81) p value 0.026], [OR 3.56 (1.37, 9.28) p value 0.009], [OR 5.94 (1.52, 23.15) p value 0.010], [OR 2.99 (1.51, 5.89) p value 0.002] and [OR 2.79 (1.37, 5.68) p value 0.005] respectively.

Conclusion: Uptake of cervical cancer screening is low despite high awareness. Strategies to improve cervical cancer screening in Kenya should be implemented with messages targeting persons with both risky and non-risky lifestyles especially younger women with no formal education living in rural areas.

Citing Articles

Multiple sexual partnership as an independent predictor of cervical cancer screening among women of reproductive age: an analysis of the 2022 Kenya demographic and health survey.

Okyere J BMC Cancer. 2025; 25(1):259.

PMID: 39953452 PMC: 11827377. DOI: 10.1186/s12885-025-13704-0.


Evaluation of pathology resources for cervical cancer detection between 2018 and 2022: a retrospective study at Moi Teaching and Referral Hospital, Western Kenya.

Anangwe N, Steimgrimson J, Cu-Uvin S BMC Cancer. 2025; 25(1):203.

PMID: 39910487 PMC: 11796189. DOI: 10.1186/s12885-025-13563-9.


"It was not normal, and I had to find a doctor and tell him." Kenyan Women's Response to Cervical Cancer Symptoms.

Mkuu R, Hungu C, Makokha F, Harvey I, Kithaka B, Mweni S J Patient Exp. 2024; 11:23743735241283200.

PMID: 39574921 PMC: 11580070. DOI: 10.1177/23743735241283200.


Factors Associated With Cervical Cancer Screening Attendance in Hungary Based on the European Health Interview Survey.

Pataki J, Szollosi G, Sarvary A, Dombradi V Int J Public Health. 2024; 69:1607509.

PMID: 39267771 PMC: 11390459. DOI: 10.3389/ijph.2024.1607509.


Evaluation of Pathology Resources for Cervical Cancer Detection Between 2018 & 2022: a Retrospective Study at Moi Teaching and Referral Hospital, Western Kenya.

Anangwe N, Steimgrimson J, Cu-Uvin S Res Sq. 2024; .

PMID: 39257969 PMC: 11384803. DOI: 10.21203/rs.3.rs-4791370/v1.


References
1.
Fitzmaurice C, Allen C, Barber R, Barregard L, Bhutta Z, Brenner H . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; 3(4):524-548. PMC: 6103527. DOI: 10.1001/jamaoncol.2016.5688. View

2.
Perlman S, Wamai R, Bain P, Welty T, Welty E, Ogembo J . Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS One. 2014; 9(3):e90912. PMC: 3949716. DOI: 10.1371/journal.pone.0090912. View

3.
Chidyaonga-Maseko F, Chirwa M, Muula A . Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors. Pan Afr Med J. 2015; 21:231. PMC: 4607967. DOI: 10.11604/pamj.2015.21.231.6350. View

4.
Cutts F, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G . Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007; 85(9):719-26. PMC: 2636411. DOI: 10.2471/blt.06.038414. View

5.
Vermandere H, Naanyu V, Mabeya H, Broeck D, Michielsen K, Degomme O . Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya. PLoS One. 2014; 9(10):e109353. PMC: 4192319. DOI: 10.1371/journal.pone.0109353. View